首页|替罗非班联合常规药物治疗对超溶栓时间窗急性脑梗死患者血清炎性因子及神经功能的影响

替罗非班联合常规药物治疗对超溶栓时间窗急性脑梗死患者血清炎性因子及神经功能的影响

扫码查看
目的 探讨替罗非班联合常规药物在超溶栓时间窗急性脑梗死(ACI)患者中的治疗效果.方法 选取 2021年 9 月—2023 年9月郓城县人民医院收治的 86 例超溶栓时间窗ACI患者为研究对象,按随机数字表法将其分为对照组和观察组,各43 例.对照组采用常规药物治疗,观察组在对照组基础上联合替罗非班治疗.对比两组的临床疗效、血清炎性因子水平、神经功能、血液流变学指标及不良反应发生情况.结果 观察组治疗总有效率为 95.35%,高于对照组的81.40%,差异有统计学意义(P<0.05).治疗后,观察组白细胞介素-6、超敏C反应蛋白、肿瘤坏死因子-α水平均低于对照组,组间差异有统计学意义(P<0.05);观察组美国国立卫生研究院卒中量表评分低于对照组,差异有统计学意义(P<0.05);观察组全血高切黏度、血浆黏度、全血低切黏度、纤维蛋白原水平均低于对照组,组间差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 替罗非班联合常规药物治疗超溶栓时间窗ACI患者可增强疗效,减轻神经损伤与炎性反应,改善血液流变学指标,且安全有效.
Effect of Tirofiban Combined with Conventional Drug Therapy on Serum Inflammatory Factors and Neurological Function in Patients with Acute Cerebral Infarction within the Time Window of Super Thrombolysis
Objective Exploring the therapeutic effect of tirofiban combined with conventional drugs in patients with acute cerebral infarction(ACI)within the time window of super thrombolysis.Methods A total of 86 patients with ACI who were admitted to Yuncheng County People's Hospital between September 2021 and September 2023 were selected as the research subjects,according to the random number table method,they were divided into a control group and an observation group,with 43 cases in each group.The control group was treated with conventional drugs,while the observation group received combined treatment with tirofiban on the basis of the control group.Compare the clinical efficacy,serum inflammatory factor levels,neurological function,hemorheological indicators,and occurrence of adverse reactions between two groups.Results The total effective rate of the observation group was 95.35%,which was higher than 81.40%of the control group,the difference was statistically significant(P<0.05).After treatment,the levels of interleukin-6,high-sensitivity C-reactive protein,and tumor necrosis factor-αin the observation group were lower than those in the control group,the differences between the groups were statistically significant(P<0.05);the National Institutes of Health Stroke Scale score of the observation group was lower than that of the control group,the difference was statistically significant(P<0.05);the observation group had lower levels of whole blood high shear viscosity,plasma viscosity,whole blood low shear viscosity,and fibrinogen compared to the control group,the differences between the groups were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of tirofiban and conventional drugs in the treatment of patients with ACI within the time window of super thrombolysis can enhance efficacy,reduce nerve damage and inflammatory reactions,improve hemorheological indicators,and is safe and effective.

Acute cerebral infarctionTirofibanAspirinClopidogrelSerum inflammatory factorsNeurological function

于婧、杜文芳

展开 >

郓城县人民医院神经内科,山东 菏泽 274700

急性脑梗死 替罗非班 阿司匹林 氯吡格雷 血清炎性因子 神经功能

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(14)